An optimum prosthesis combination of low-risk total knee arthroplasty options in all five primary categories of design results in a 60% reduction in revision risk: a registry analysis of 482,373 prostheses.

Benchmarking Decision making Knee arthroplasty Knee arthroplasty revision Knee replacement Prosthesis design Prosthesis outcomes Registry data

Journal

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA
ISSN: 1433-7347
Titre abrégé: Knee Surg Sports Traumatol Arthrosc
Pays: Germany
ID NLM: 9314730

Informations de publication

Date de publication:
May 2019
Historique:
received: 11 06 2018
accepted: 10 08 2018
pubmed: 22 8 2018
medline: 3 8 2019
entrez: 22 8 2018
Statut: ppublish

Résumé

Decades of innovations in total knee arthroplasty (TKA) design have led to large number of possible prosthesis combinations in regards fixation, posterior stability, bearing mobility, bearing surface, and patella resurfacing, each of which can alter the revision risk. The accumulative effect when the lowest risk combination in each design category, or "Optimum Prosthesis Combination" (OPC) is utilized remains unknown. The purpose of this analysis was to first, identify the OPC and second, to compare the revision risk of a cohort who received the OPC to a cohort who received an Alternative Prosthesis Combination (APC). National registry revision risk data for primary TKA for osteoarthritis were obtained from September 1999 to December 2015 for two patient cohorts, those receiving an OPC and those receiving an APC. OPC was defined as TKA with the lowest revision risk option for five primary TKA design categories; fixation, posterior stability, bearing mobility, bearing surface, and patella resurfacing, while APC had one or more higher risk options. Of the 482,373 included TKA, 42,008 (8.7%) were in the OPC cohort, who received a minimally stabilized, fixed bearing TKA with cross-linked polyethylene with patella resurfacing. Both cohorts had similar demographics. At 10 years, the OPC cohort had a Cumulative Percent Revision of 2.4% (95% CI 2.1, 2.8) compared to 5.5% (95% CI 5.4, 5.6) for the APC cohort. For all patients, revision risk of the APC cohort was higher at all times [151% greater at ≥ 3 years (p < 0.001)]. Loosening/lysis was the most common cause of revision in the ACP cohort (1.1%), while it was the second most common cause in the OPC cohort (0.3%). The increased risk was apparent in all age and gender subgroups, with the highest risk increase seen in males ≥ 65 years. Patients receiving the lowest risk prosthesis design combination or Optimum Prosthesis Combination TKA had a 60% lower revision risk, with similar demographics to the Alternative Prosthesis Combination TKA. III.

Identifiants

pubmed: 30128685
doi: 10.1007/s00167-018-5115-z
pii: 10.1007/s00167-018-5115-z
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1418-1426

Références

Acta Orthop Scand. 2000 Jun;71(3):262-7
pubmed: 10919297
J South Orthop Assoc. 2002 Winter;11(4):218-26
pubmed: 12597066
J Bone Joint Surg Br. 2007 Aug;89(8):1042-5
pubmed: 17785742
JAMA. 2009 Aug 19;302(7):790-1
pubmed: 19690313
Acta Orthop. 2010 Feb;81(1):108-13
pubmed: 19968604
Acta Orthop. 2010 Feb;81(1):8-9
pubmed: 20170422
Clin Orthop Relat Res. 2011 Jan;469(1):48-54
pubmed: 20568026
J Bone Joint Surg Am. 2011 Dec 21;93 Suppl 3:48-50
pubmed: 22262423
Lancet. 2012 Apr 7;379(9823):1331-40
pubmed: 22398175
Acta Orthop. 2013 Apr;84(2):145-52
pubmed: 23485105
Bone Joint J. 2013 Nov;95-B(11 Suppl A):129-32
pubmed: 24187370
J Bone Joint Surg Am. 2014 Dec 17;96 Suppl 1:52-8
pubmed: 25520419
J Bone Joint Surg Am. 2014 Dec 17;96 Suppl 1:59-64
pubmed: 25520420
J Bone Joint Surg Am. 2014 Dec 17;96 Suppl 1:65-72
pubmed: 25520421
Knee Surg Relat Res. 2016 Mar;28(1):1-15
pubmed: 26955608
J Arthroplasty. 2017 Feb;32(2):419-425
pubmed: 27593732
Ann Transl Med. 2016 Sep;4(18):339
pubmed: 27761443
Osteoarthritis Cartilage. 2017 Apr;25(4):455-461
pubmed: 27856293
J Arthroplasty. 2017 May;32(5):1510-1515
pubmed: 28082042
J Arthroplasty. 2017 Oct;32(10):2980-2989
pubmed: 28552448
J Bone Joint Surg Am. 2017 Jul 5;99(13):1129-1139
pubmed: 28678126
J Bone Joint Surg Am. 2018 Jan 17;100(2):115-123
pubmed: 29342061
Acta Orthop. 2018 Jun;89(3):329-335
pubmed: 29528754
BMJ. 1996 Jan 13;312(7023):71-2
pubmed: 8555924

Auteurs

Christopher J Vertullo (CJ)

Knee Research Australia, 8-10 Carrara Street, Benowa, QLD, 4217, Australia. Chris.vertullo@icloud.com.
Gold Coast Orthopaedic Research and Education Alliance, Menzies Health Institute Queensland, Griffith University, Southport, QLD, 4222, Australia. Chris.vertullo@icloud.com.

Stephen E Graves (SE)

Australian Orthopaedic Association National Joint Replacement Registry, South Australian Health and Medical Research Institute, North Terrace, Adelaide, SA, 5000, Australia.

Yi Peng (Y)

Australian Orthopaedic Association National Joint Replacement Registry, South Australian Health and Medical Research Institute, North Terrace, Adelaide, SA, 5000, Australia.

Peter L Lewis (PL)

Australian Orthopaedic Association National Joint Replacement Registry, South Australian Health and Medical Research Institute, North Terrace, Adelaide, SA, 5000, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH